Skip to main content

Table 2 IMES, clinical, and motivation variables before and after training

From: Autonomy support encourages use of more-affected arm post-stroke

 

Control

Autonomy support

Group p

 

Pre

Post

P

Pre

Post

P

 

IMES variables

       

 Use

36.85 ± 31.29

30.74 ± 17.97

0.927

20.87 ± 28.17

66.74 ± 30.31

< 0.001***

< 0.001***

 Impairment

0.62 ± 0.27a

0.61 ± 0.3

P = 0.07

0.64 ± 0.23

0.48 ± 0.13

P = 0.07

0.326

 Performance

39.44 ± 26.87

62.03 ± 30.23

< 0.001***

39.52 ± 26.73

74.60 ± 26.68

< 0.001***

0.535

Clinical variables

       

 AAUT-QOM

2.21 ± 1.2

2.30 ± 1.21

0.836

1.9 ± 1.53

1.86 ± 1.39

0.836

0.451

 FMA-UE

45.92 ± 12.24

50 ± 10.57

< 0.001***

42.00 ± 17.28

45.64 ± 16.86

< 0.001***

0.472

 WMFT

0.63 ± 0.21

0.51 ± 0.11

< 0.001***

0.71 ± 0.34

0.56 ± 0.20

< 0.001***

0.474

Motivation variables

       

 Self-efficacy

57.10 ± 20.21

67.38 ± 26.77

0.002**

55.76 ± 28.45

70.34 ± 23.47

0.002**

0.927

  1. aMean ± Standard Deviation, *p < 0.05, **p < 0.01, ***p < 0.001
  2. Impairment in IMES variables was represented as a log-transformed movement duration and performance and use in IMES variables were represented as a percentage. AAUT-QOM, Actual Amount of Use Test with Quality of Movement scale; FMA-UE, Fugl-Meyer Assessment for Upper Extremity; WMFT, Wolf Motor Function Test; pre, pre-training test; post, post-training test. P denotes the significance level for comparisons between pre- and post-training within each group. Group p indicates the significance level when comparing pre-and post-training changes between the control and autonomy support groups
Back to article page

Journal of NeuroEngineering and Rehabilitation

ISSN: 1743-0003

Contact us